MAPK13 and ischemia: In intestinal ischemia–reperfusion (II/R) injury, miR-351-5p was shown to target MAPK13 and sirtuin-6, activate the Bcl2-1/NF-κB signaling pathway and cleave caspase-3, which promotes cell death [39].